| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 2.30e-07 | 15 | 74 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.35e-04 | 5 | 74 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 2.04e-04 | 31 | 74 | 3 | GO:0051393 | |
| GeneOntologyBiologicalProcess | female meiosis II | 2.15e-09 | 6 | 73 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 2.15e-09 | 6 | 73 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 2.15e-09 | 6 | 73 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 6.60e-07 | 47 | 73 | 5 | GO:0001556 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.38e-06 | 99 | 73 | 6 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 1.74e-06 | 103 | 73 | 6 | GO:0009994 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 2.03e-06 | 26 | 73 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 3.21e-06 | 29 | 73 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 4.23e-06 | 31 | 73 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 4.23e-06 | 68 | 73 | 5 | GO:0007528 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 8.73e-06 | 37 | 73 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.63e-05 | 418 | 73 | 9 | GO:0009895 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.91e-05 | 156 | 73 | 6 | GO:0048477 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 1.93e-05 | 45 | 73 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 3.30e-05 | 172 | 73 | 6 | GO:0051783 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | 3.31e-05 | 574 | 73 | 10 | GO:0010638 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 3.44e-05 | 52 | 73 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | TUT4 THRA PHF20L1 MYCBP2 DAZ4 KLHL40 APC DAZ1 PRKAG2 DAZ3 DAZ2 MDM4 MEFV PINK1 | 1.09e-04 | 1252 | 73 | 14 | GO:0009894 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | BRINP3 ZNF274 DAZ4 BTN2A3P APC MRGPRX3 YY1AP1 DAZ1 FGFR2 DAZ3 DAZ2 MDM4 BIRC6 PLK4 | 1.12e-04 | 1256 | 73 | 14 | GO:0051726 |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling by trans-synaptic protein complex | 1.23e-04 | 5 | 73 | 2 | GO:0098942 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.23e-04 | 5 | 73 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | female gamete generation | 1.39e-04 | 223 | 73 | 6 | GO:0007292 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 1.45e-04 | 75 | 73 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.61e-04 | 77 | 73 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.98e-04 | 151 | 73 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 2.05e-04 | 82 | 73 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | DOC2A MYCBP2 PIK3R1 DAZ4 TRPM2 APC DAZ1 FGFR2 DAZ3 DAZ2 FERMT2 MAPKAPK5 PLK4 PINK1 | 2.25e-04 | 1342 | 73 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 2.55e-04 | 354 | 73 | 7 | GO:0071695 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.57e-04 | 87 | 73 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 2.63e-04 | 251 | 73 | 6 | GO:2000241 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 2.69e-04 | 88 | 73 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 3.06e-04 | 91 | 73 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | cell maturation | 3.66e-04 | 267 | 73 | 6 | GO:0048469 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 4.55e-04 | 101 | 73 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | lung-associated mesenchyme development | 5.46e-04 | 10 | 73 | 2 | GO:0060484 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 5.88e-04 | 407 | 73 | 7 | GO:0045787 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 6.56e-04 | 48 | 73 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 6.56e-04 | 48 | 73 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by trans-synaptic complex | 6.66e-04 | 11 | 73 | 2 | GO:0099545 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 7.42e-04 | 115 | 73 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 7.57e-04 | 845 | 73 | 10 | GO:0010564 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 7.64e-04 | 307 | 73 | 6 | GO:0090068 | |
| GeneOntologyBiologicalProcess | cellular response to manganese ion | 7.97e-04 | 12 | 73 | 2 | GO:0071287 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 8.17e-04 | 118 | 73 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | THRA MYCBP2 PIK3R1 FARP1 TRPM2 APC DAG1 FNBP1L FERMT2 PLK4 MEFV PINK1 | 8.94e-04 | 1189 | 73 | 12 | GO:0044087 |
| GeneOntologyBiologicalProcess | organelle fission | 9.09e-04 | 571 | 73 | 8 | GO:0048285 | |
| GeneOntologyBiologicalProcess | developmental maturation | 9.17e-04 | 439 | 73 | 7 | GO:0021700 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DOC2A PIK3R1 DAZ4 APC DAG1 DAZ1 FNBP1L DAZ3 DAZ2 FERMT2 MAPKAPK5 PLK4 PINK1 | 9.22e-04 | 1366 | 73 | 13 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | CACNA1C CACNA1D RAPGEF6 NLRP1 FGFR2 PRKAG2 FERMT2 MAPKAPK5 MEFV PREX2 PINK1 | 9.32e-04 | 1028 | 73 | 11 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of filopodium assembly | 1.09e-03 | 57 | 73 | 3 | GO:0051489 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 1.13e-03 | 591 | 73 | 8 | GO:1903829 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 1.14e-03 | 129 | 73 | 4 | GO:0002027 | |
| MousePheno | abnormal lateral ventricle morphology | 9.75e-07 | 164 | 66 | 8 | MP:0000823 | |
| Domain | DUF4062 | 1.59e-05 | 2 | 75 | 2 | PF13271 | |
| Domain | DUF4062 | 1.59e-05 | 2 | 75 | 2 | IPR025139 | |
| Domain | CAC1F_C | 4.76e-05 | 3 | 75 | 2 | IPR031688 | |
| Domain | CAC1F_C | 4.76e-05 | 3 | 75 | 2 | PF16885 | |
| Domain | VDCC_L_a1su | 9.50e-05 | 4 | 75 | 2 | IPR005446 | |
| Domain | Liprin | 2.36e-04 | 6 | 75 | 2 | IPR029515 | |
| Domain | VDCC_a1su_IQ | 3.30e-04 | 7 | 75 | 2 | IPR014873 | |
| Domain | GPHH | 3.30e-04 | 7 | 75 | 2 | PF16905 | |
| Domain | GPHH_dom | 3.30e-04 | 7 | 75 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 3.30e-04 | 7 | 75 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 3.30e-04 | 7 | 75 | 2 | PF08763 | |
| Domain | VDCCAlpha1 | 7.01e-04 | 10 | 75 | 2 | IPR002077 | |
| Domain | RRM_1 | 1.50e-03 | 208 | 75 | 5 | PF00076 | |
| Domain | RRM | 1.80e-03 | 217 | 75 | 5 | SM00360 | |
| Domain | DH_1 | 2.08e-03 | 63 | 75 | 3 | PS00741 | |
| Domain | RRM_dom | 2.20e-03 | 227 | 75 | 5 | IPR000504 | |
| Domain | RRM | 2.32e-03 | 230 | 75 | 5 | PS50102 | |
| Domain | RhoGEF | 2.58e-03 | 68 | 75 | 3 | SM00325 | |
| Domain | RhoGEF | 2.81e-03 | 70 | 75 | 3 | PF00621 | |
| Domain | DH_2 | 2.81e-03 | 70 | 75 | 3 | PS50010 | |
| Domain | DH-domain | 2.92e-03 | 71 | 75 | 3 | IPR000219 | |
| Domain | - | 2.92e-03 | 71 | 75 | 3 | 1.20.900.10 | |
| Domain | - | 3.00e-03 | 244 | 75 | 5 | 3.30.70.330 | |
| Domain | DAPIN | 3.49e-03 | 22 | 75 | 2 | PS50824 | |
| Domain | PYRIN | 3.49e-03 | 22 | 75 | 2 | PF02758 | |
| Domain | DAPIN | 3.49e-03 | 22 | 75 | 2 | IPR004020 | |
| Domain | PYRIN | 3.49e-03 | 22 | 75 | 2 | SM01289 | |
| Domain | Nucleotide-bd_a/b_plait | 3.80e-03 | 258 | 75 | 5 | IPR012677 | |
| Domain | NACHT | 3.81e-03 | 23 | 75 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 3.81e-03 | 23 | 75 | 2 | IPR007111 | |
| Domain | TUDOR | 5.23e-03 | 27 | 75 | 2 | SM00333 | |
| Domain | Tudor | 6.44e-03 | 30 | 75 | 2 | IPR002999 | |
| Domain | ZF_PHD_1 | 6.80e-03 | 96 | 75 | 3 | PS01359 | |
| Domain | FERM_N | 7.75e-03 | 33 | 75 | 2 | PF09379 | |
| Domain | FERM_N | 7.75e-03 | 33 | 75 | 2 | IPR018979 | |
| Pathway | WP_OVARIAN_INFERTILITY | 1.60e-05 | 35 | 62 | 4 | MM15948 | |
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 7670487 | ||
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 11694340 | ||
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 9321470 | ||
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 1.99e-11 | 4 | 75 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 1.99e-11 | 4 | 75 | 4 | 11688365 | |
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 1.99e-11 | 4 | 75 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 1.99e-11 | 4 | 75 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 1.99e-11 | 4 | 75 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 1.99e-11 | 4 | 75 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 1.99e-11 | 4 | 75 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 1.99e-11 | 4 | 75 | 4 | 16963411 | |
| Pubmed | 8.03e-11 | 14 | 75 | 5 | 25457166 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 23579190 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 9.95e-11 | 5 | 75 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 9.95e-11 | 5 | 75 | 4 | 17416365 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 22293198 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 9.95e-11 | 5 | 75 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 9.95e-11 | 5 | 75 | 4 | 8968756 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 9.95e-11 | 5 | 75 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 9.95e-11 | 5 | 75 | 4 | 26411291 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 9.95e-11 | 5 | 75 | 4 | 14648873 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 8896558 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 9.95e-11 | 5 | 75 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 9.95e-11 | 5 | 75 | 4 | 9288969 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 9.95e-11 | 5 | 75 | 4 | 10903443 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 9.95e-11 | 5 | 75 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 9.95e-11 | 5 | 75 | 4 | 8845845 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 9.95e-11 | 5 | 75 | 4 | 19783541 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 17761180 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 9.95e-11 | 5 | 75 | 4 | 12200456 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 11514340 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 9.95e-11 | 5 | 75 | 4 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 9.95e-11 | 5 | 75 | 4 | 23223451 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 11804965 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 21270429 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 8661148 | ||
| Pubmed | 1.20e-10 | 15 | 75 | 5 | 35772791 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 2.98e-10 | 6 | 75 | 4 | 18452650 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 2.98e-10 | 6 | 75 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 2.98e-10 | 6 | 75 | 4 | 31355046 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 20157580 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 2.98e-10 | 6 | 75 | 4 | 26077710 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 17526644 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 2.98e-10 | 6 | 75 | 4 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 2.98e-10 | 6 | 75 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 2.98e-10 | 6 | 75 | 4 | 23417416 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 32170089 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 16278232 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 2.98e-10 | 6 | 75 | 4 | 16001084 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 2.98e-10 | 6 | 75 | 4 | 1869307 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 11390979 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 27632217 | ||
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 15081113 | ||
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 22699423 | ||
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 6.95e-10 | 7 | 75 | 4 | 16946704 | |
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 10857750 | ||
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 6.95e-10 | 7 | 75 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 6.95e-10 | 7 | 75 | 4 | 26826184 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 1.39e-09 | 8 | 75 | 4 | 23204224 | |
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 29883445 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 10823932 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 11869379 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 1.39e-09 | 8 | 75 | 4 | 32339196 | |
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 33749946 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 22621333 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 32686646 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 2.49e-09 | 9 | 75 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 2.49e-09 | 9 | 75 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 2.49e-09 | 9 | 75 | 4 | 19695304 | |
| Pubmed | 2.49e-09 | 9 | 75 | 4 | 28235998 | ||
| Pubmed | 2.49e-09 | 9 | 75 | 4 | 20159962 | ||
| Pubmed | 3.04e-09 | 58 | 75 | 6 | 25142465 | ||
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 4.15e-09 | 10 | 75 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 4.15e-09 | 10 | 75 | 4 | 38433229 | |
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 23810942 | ||
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 12837688 | ||
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 10601091 | ||
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 9922113 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 6.51e-09 | 11 | 75 | 4 | 34401671 | |
| Cytoband | Yq11.223 | 1.72e-05 | 93 | 75 | 4 | Yq11.223 | |
| Cytoband | 1p22.1 | 1.27e-03 | 32 | 75 | 2 | 1p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 1.50e-03 | 137 | 75 | 3 | chr1p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 1.72e-03 | 311 | 75 | 4 | chrYq11 | |
| Cytoband | 4p14 | 2.17e-03 | 42 | 75 | 2 | 4p14 | |
| GeneFamily | RNA binding motif containing | 5.51e-04 | 213 | 57 | 5 | 725 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 2.80e-03 | 25 | 57 | 2 | 994 | |
| GeneFamily | PHD finger proteins | 2.87e-03 | 90 | 57 | 3 | 88 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.02e-03 | 26 | 57 | 2 | 253 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 3.01e-08 | 12 | 75 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 3.01e-08 | 12 | 75 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 5.25e-07 | 23 | 75 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 1.83e-06 | 31 | 75 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 2.38e-06 | 33 | 75 | 4 | MM701 | |
| Coexpression | MADAN_DPPA4_TARGETS | 4.87e-06 | 86 | 75 | 5 | MM1312 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 2.31e-05 | 199 | 75 | 6 | M4526 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP | 2.59e-05 | 203 | 75 | 6 | M10184 | |
| Coexpression | MCCABE_BOUND_BY_HOXC6 | 5.19e-05 | 461 | 75 | 8 | M6376 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CHL1 BDP1 CACNA1C TUT4 RAPGEF6 THRA ST3GAL5 MYCBP2 PPFIBP1 APC GRIK2 FNBP1L | 6.73e-05 | 1106 | 75 | 12 | M39071 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 8.16e-05 | 363 | 75 | 7 | M41103 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.58e-08 | 199 | 75 | 7 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.74e-08 | 200 | 75 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 170 | 75 | 5 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 175 | 75 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 182 | 75 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 186 | 75 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 187 | 75 | 5 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 1.69e-05 | 189 | 75 | 5 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.73e-05 | 190 | 75 | 5 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 191 | 75 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 194 | 75 | 5 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.16e-05 | 199 | 75 | 5 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.16e-05 | 199 | 75 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 2.16e-05 | 199 | 75 | 5 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Control-Control-Others-HSPC|Control / Disease, condition lineage and cell class | 2.16e-05 | 199 | 75 | 5 | b71169be0d916b2ed139a3122d78bb154c71edb4 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-05 | 199 | 75 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.16e-05 | 199 | 75 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.21e-05 | 200 | 75 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 2.21e-05 | 200 | 75 | 5 | 09deb831fc2c8a8867cc850f3aa094a5e48489ff | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 148 | 75 | 4 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-04 | 152 | 75 | 4 | 931c10245cde9b3290224cc1da46b2bf300b9ac2 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 1.40e-04 | 156 | 75 | 4 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 156 | 75 | 4 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.65e-04 | 163 | 75 | 4 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 164 | 75 | 4 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.94e-04 | 170 | 75 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-04 | 170 | 75 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.94e-04 | 170 | 75 | 4 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | control-Myeloid-Eosinophils|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.98e-04 | 171 | 75 | 4 | 82f736c33ed96c0865618e8f8eb82a5487126bdc | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.98e-04 | 171 | 75 | 4 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 171 | 75 | 4 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-04 | 172 | 75 | 4 | 9dca1542145d88559527db7e0f6ad150df59ca2d | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 2.03e-04 | 172 | 75 | 4 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.03e-04 | 172 | 75 | 4 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 2.31e-04 | 178 | 75 | 4 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.31e-04 | 178 | 75 | 4 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.41e-04 | 180 | 75 | 4 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 181 | 75 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 181 | 75 | 4 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.52e-04 | 182 | 75 | 4 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.52e-04 | 182 | 75 | 4 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 2.57e-04 | 183 | 75 | 4 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 2.57e-04 | 183 | 75 | 4 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.57e-04 | 183 | 75 | 4 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 2.57e-04 | 183 | 75 | 4 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 183 | 75 | 4 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-04 | 184 | 75 | 4 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.62e-04 | 184 | 75 | 4 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.62e-04 | 184 | 75 | 4 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 184 | 75 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.62e-04 | 184 | 75 | 4 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | COVID-19_Moderate-HSPC|World / disease group, cell group and cell class | 2.62e-04 | 184 | 75 | 4 | ccc93babe1fcdeb66b78e1d8414357877a7c45bd | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-04 | 184 | 75 | 4 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-04 | 184 | 75 | 4 | 492c680f0769ba4e651d09c2e8e5d5d271ed08aa | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.62e-04 | 184 | 75 | 4 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 185 | 75 | 4 | 3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 185 | 75 | 4 | 995a8ddc3fd8e6879d8b5de8cbdefe232d34833b | |
| ToppCell | COVID-19_Moderate-HSPC|COVID-19_Moderate / disease group, cell group and cell class | 2.68e-04 | 185 | 75 | 4 | cacc6ab5f26f6c803894567fb838ea06eaa7efe5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 186 | 75 | 4 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.73e-04 | 186 | 75 | 4 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 186 | 75 | 4 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-04 | 187 | 75 | 4 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | 16e55d802fc4e71878305e61ad03806aabd59537 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 2.79e-04 | 187 | 75 | 4 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.85e-04 | 188 | 75 | 4 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-04 | 188 | 75 | 4 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 2.90e-04 | 189 | 75 | 4 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 189 | 75 | 4 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.90e-04 | 189 | 75 | 4 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.90e-04 | 189 | 75 | 4 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 189 | 75 | 4 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 189 | 75 | 4 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.96e-04 | 190 | 75 | 4 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-04 | 190 | 75 | 4 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 190 | 75 | 4 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.96e-04 | 190 | 75 | 4 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 190 | 75 | 4 | ff3dec5b45c6ea9b5319fb51a0198c6773b7be26 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-04 | 190 | 75 | 4 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 190 | 75 | 4 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 190 | 75 | 4 | 4971857eac9af17d66d673ed2ab7072639f60a10 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.02e-04 | 191 | 75 | 4 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.14e-04 | 193 | 75 | 4 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-04 | 193 | 75 | 4 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-04 | 193 | 75 | 4 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-04 | 193 | 75 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-04 | 193 | 75 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-04 | 193 | 75 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 194 | 75 | 4 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 194 | 75 | 4 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-04 | 194 | 75 | 4 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.21e-04 | 194 | 75 | 4 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 195 | 75 | 4 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 195 | 75 | 4 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-04 | 195 | 75 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 3.33e-04 | 196 | 75 | 4 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| Drug | boron trichloride | 1.62e-09 | 6 | 75 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 1.92e-07 | 16 | 75 | 4 | CID000162558 | |
| Drug | 2-chlorodideoxyadenosine | 2.96e-07 | 43 | 75 | 5 | CID000072194 | |
| Drug | dazmegrel | 4.05e-07 | 19 | 75 | 4 | CID000053555 | |
| Drug | YM 026 | 4.05e-07 | 19 | 75 | 4 | CID000004443 | |
| Drug | AZFd | 9.17e-07 | 23 | 75 | 4 | CID000196489 | |
| Drug | dansylaziridine | 9.17e-07 | 23 | 75 | 4 | CID000104008 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.51e-06 | 184 | 75 | 7 | 2321_DN | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 3.00e-06 | 189 | 75 | 7 | 5936_DN | |
| Drug | d-gluconhydroximo-1,5-lactam | 3.19e-06 | 31 | 75 | 4 | CID000003479 | |
| Drug | ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 3.44e-06 | 193 | 75 | 7 | 974_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.68e-06 | 195 | 75 | 7 | 4748_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.68e-06 | 195 | 75 | 7 | 3268_UP | |
| Drug | Vistar | 5.91e-06 | 36 | 75 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 5.91e-06 | 36 | 75 | 4 | CID000001649 | |
| Drug | molybdenum disulfide | 1.22e-05 | 43 | 75 | 4 | CID000014823 | |
| Drug | propham | 1.33e-05 | 44 | 75 | 4 | CID000024685 | |
| Drug | FPL 64176 | 1.52e-05 | 15 | 75 | 3 | CID000003423 | |
| Drug | ridogrel | 2.61e-05 | 52 | 75 | 4 | CID005362391 | |
| Drug | azafagomine | 3.76e-05 | 57 | 75 | 4 | CID011957435 | |
| Drug | Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 4.50e-05 | 195 | 75 | 6 | 7434_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 4.50e-05 | 195 | 75 | 6 | 4980_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 2783_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; HL60; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 2463_DN | |
| Drug | Noscapine [128-62-1]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.04e-05 | 199 | 75 | 6 | 2745_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 5.19e-05 | 200 | 75 | 6 | 3477_DN | |
| Drug | NSC56408 | 5.24e-05 | 62 | 75 | 4 | CID000005604 | |
| Drug | EGTA-AM | 5.24e-05 | 62 | 75 | 4 | CID000121907 | |
| Drug | NSC-686960 | 6.40e-05 | 4 | 75 | 2 | CID000192816 | |
| Drug | Linuron | 6.54e-05 | 128 | 75 | 5 | ctd:D008044 | |
| Drug | kt S | 6.71e-05 | 66 | 75 | 4 | CID006399216 | |
| Drug | azelastine | 1.05e-04 | 74 | 75 | 4 | CID000002267 | |
| Drug | Nilvadipine | 1.06e-04 | 5 | 75 | 2 | DB06712 | |
| Drug | Nisoldipine | 1.06e-04 | 5 | 75 | 2 | DB00401 | |
| Drug | B 874-67 | 1.06e-04 | 5 | 75 | 2 | CID000195466 | |
| Drug | methyl beta-aminocrotonate | 1.06e-04 | 5 | 75 | 2 | CID000084253 | |
| Drug | nemadipine-A | 1.06e-04 | 5 | 75 | 2 | CID002856102 | |
| Drug | p11-13 | 1.11e-04 | 75 | 75 | 4 | CID000015759 | |
| Drug | remifentanil | 1.59e-04 | 32 | 75 | 3 | CID000060814 | |
| Drug | CPU-23 | 1.59e-04 | 6 | 75 | 2 | CID003036051 | |
| Drug | procymidone | 1.61e-04 | 155 | 75 | 5 | ctd:C035988 | |
| Disease | Male sterility due to Y-chromosome deletions | 2.39e-09 | 8 | 73 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 2.39e-09 | 8 | 73 | 4 | C1507149 | |
| Disease | Anemia, Macrocytic | 6.04e-06 | 2 | 73 | 2 | C0002886 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 7.95e-06 | 16 | 73 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 7.95e-06 | 16 | 73 | 3 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 7.95e-06 | 16 | 73 | 3 | cv:C1839071 | |
| Disease | Glioblastoma Multiforme | 8.43e-06 | 111 | 73 | 5 | C1621958 | |
| Disease | Manic Disorder | 2.95e-05 | 71 | 73 | 4 | C0024713 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.61e-05 | 4 | 73 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Manic | 4.28e-05 | 78 | 73 | 4 | C0338831 | |
| Disease | Depression, Bipolar | 4.50e-05 | 79 | 73 | 4 | C0005587 | |
| Disease | response to angiotensin receptor blocker | 5.62e-05 | 30 | 73 | 3 | EFO_0010735 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 8.81e-05 | 181 | 73 | 5 | DOID:684 (is_implicated_in) | |
| Disease | impulse control disorder | 9.00e-05 | 6 | 73 | 2 | MONDO_0001162 | |
| Disease | Psychotic Disorders | 1.17e-04 | 101 | 73 | 4 | C0033975 | |
| Disease | Bipolar Disorder | 1.79e-04 | 477 | 73 | 7 | C0005586 | |
| Disease | Malignant Neoplasms | 2.92e-04 | 128 | 73 | 4 | C0006826 | |
| Disease | Gastric cancer | 3.27e-04 | 11 | 73 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 3.27e-04 | 11 | 73 | 2 | cv:C0038356 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 3.27e-04 | 11 | 73 | 2 | EFO_0801871 | |
| Disease | GASTRIC CANCER | 3.27e-04 | 11 | 73 | 2 | 613659 | |
| Disease | endometrial carcinoma (is_implicated_in) | 3.92e-04 | 12 | 73 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | Nonorganic psychosis | 6.77e-04 | 69 | 73 | 3 | C0349204 | |
| Disease | stomach cancer (is_implicated_in) | 7.67e-04 | 72 | 73 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | Benign neoplasm of stomach | 8.02e-04 | 17 | 73 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 8.02e-04 | 17 | 73 | 2 | C0496905 | |
| Disease | Limb Deformities, Congenital | 8.02e-04 | 17 | 73 | 2 | C0206762 | |
| Disease | Carcinoma in situ of stomach | 8.02e-04 | 17 | 73 | 2 | C0154060 | |
| Disease | Mood Disorders | 8.13e-04 | 168 | 73 | 4 | C0525045 | |
| Disease | Prostatic Neoplasms | 8.27e-04 | 616 | 73 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.27e-04 | 616 | 73 | 7 | C0376358 | |
| Disease | interleukin 18 measurement | 8.97e-04 | 76 | 73 | 3 | EFO_0004581 | |
| Disease | Glioblastoma | 1.00e-03 | 79 | 73 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.20e-03 | 84 | 73 | 3 | C0334588 | |
| Disease | Stomach Carcinoma | 1.23e-03 | 21 | 73 | 2 | C0699791 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 1.35e-03 | 22 | 73 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | Schizophrenia | 1.50e-03 | 883 | 73 | 8 | C0036341 | |
| Disease | cortical thickness | KIF6 SF3B1 KMT2B MYCBP2 PIK3R1 PPFIBP1 EBNA1BP2 FNBP1L PRKAG2 | 1.67e-03 | 1113 | 73 | 9 | EFO_0004840 |
| Disease | cortical surface area measurement | DCHS2 KIF6 SF3B1 MYCBP2 PIK3R1 PPFIBP1 APC FGFR2 FNBP1L PRKAG2 | 1.70e-03 | 1345 | 73 | 10 | EFO_0010736 |
| Disease | Bell's palsy | 2.09e-03 | 102 | 73 | 3 | EFO_0007167 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RHRELVVPQLPARKK | 571 | Q96KV6 | |
| HSLPVRKKVLAPRVN | 236 | Q6NS38 | |
| KRCHKQPLISLPRQR | 381 | Q76B58 | |
| SLIKNKIHRLPVIDP | 376 | Q9UGJ0 | |
| LNQVPILRTRFQKPK | 801 | A6H8Y1 | |
| RPVVRLPSLKHQSNK | 1241 | Q9NR09 | |
| IPQDLLHKVLKSPRL | 251 | Q32M84 | |
| SKLPPVNLIHRDILR | 86 | Q7L190 | |
| KDPKAIPVIHRLQLI | 676 | Q6Q4G3 | |
| KQKLCARHVQPRPLV | 116 | Q13117 | |
| KQKLCARHVQPRPLV | 116 | Q9NR90 | |
| QRLLPVVSSLPKLRH | 916 | Q9ULI1 | |
| LVHKRSPLRRNQKTP | 11 | Q9Y483 | |
| SQPAVHKLTKRIPLR | 411 | P21802 | |
| PLHSVNNPILRKRKL | 351 | Q8IW41 | |
| TIKKQPLHQFVQRPL | 31 | Q9UMS0 | |
| KLRVSPKNPRIPKLH | 516 | O00533 | |
| LKTKPIHTIIRKRAP | 1031 | Q8IWI9 | |
| QVRPKLPLLKILHAA | 26 | O15151 | |
| QLLNIPPNKTLLRRH | 851 | Q86W92 | |
| VLKLNRNRISAIPPK | 196 | Q6UXM1 | |
| HPRLVTLRKKVQAIP | 171 | O60760 | |
| NKKPPLPKRVRRQIH | 301 | Q14118 | |
| VLAVLPRLHQLKVPT | 116 | Q99848 | |
| KQLAPHPNIIRVLRA | 266 | Q9BXM7 | |
| QKFTQLLLLQRPHPR | 276 | Q9C000 | |
| IQIFARVKPPVRKHQ | 6 | Q6ZMV9 | |
| HPLVRAQPELLRKVQ | 241 | Q2TBA0 | |
| KPTLQPVLQLKARRR | 1126 | Q9UMN6 | |
| PLPQCKRHLKQVQLL | 371 | O15553 | |
| RLINIRHPISKILSP | 86 | Q96LB0 | |
| QLLKKLIRSPSIPHQ | 221 | P27986 | |
| IPPQKTLLRRHLTTK | 766 | Q8ND30 | |
| NIRHLIIPENLKPTK | 1406 | Q6V1P9 | |
| KIPLIHRALQLAQRP | 196 | P04062 | |
| LIKPHQRITKYPLLL | 306 | Q3KR16 | |
| QKKTFEINPRHPLIR | 681 | P14625 | |
| KPPRAHELKLLVRNI | 256 | Q9Y426 | |
| KQKLCARHVQPRPLV | 116 | Q9NQZ3 | |
| KQKLCARHVQPRPLV | 281 | Q9NQZ3 | |
| KQKLCARHVQPRPLV | 446 | Q9NQZ3 | |
| KHLDVVTLLRRIQPP | 1561 | Q13936 | |
| VPLRRLKPSQKKHFN | 196 | Q14183 | |
| SHLPPEQRRKKLQQR | 396 | Q5T0N5 | |
| DLLKPIVKQIRRPKH | 96 | Q9Y4F1 | |
| PLVLTEPTRNRLQKK | 846 | Q9UI17 | |
| HKKKLRSPQILVPTL | 1216 | Q9H583 | |
| KQKLCARHVQPRPLV | 116 | Q86SG3 | |
| KQKLCARHVQPRPLV | 281 | Q86SG3 | |
| VLVHIPKQRLGLVKR | 101 | Q8N9H9 | |
| NIRHPEELSLLKKPR | 131 | Q96AC1 | |
| CQRRLKHKPQAPVIV | 871 | Q13002 | |
| SIIKRHPPQRLQKLE | 91 | Q9NVL8 | |
| KHLDVVTLLRRIQPP | 1501 | Q01668 | |
| DPLARLPQLKRHIKQ | 986 | A8MW92 | |
| PRLKLLLNHTNILRP | 176 | Q6NXP6 | |
| LQLQKAKPLTHRRPK | 191 | Q96L03 | |
| RPRVKKLHPQQVLNR | 161 | P0C7P3 | |
| VLQVPAVNLHPIRKK | 1181 | Q8TEU7 | |
| KRTIQLPHLKTLILN | 366 | Q9BXR5 | |
| RKLRNVSNLKPVPLI | 211 | Q8NBX0 | |
| LQPKHFRILNPVIIK | 301 | Q9UNP4 | |
| KQHSILPARVKAIPR | 3486 | O75592 | |
| RSLKQHPPLLLDTVK | 186 | O75192 | |
| TSPLVAHRLKPIRQK | 591 | O00444 | |
| KLLPSQNRLQPQKHV | 1616 | P25054 | |
| HLPTTKELAKRQRLP | 2756 | O15417 | |
| PLIPKKFQLNQHRRI | 211 | Q96HI0 | |
| LQPKRPKTIKQRHVR | 266 | Q96LT9 | |
| PPRFTLKKLVQRLHI | 436 | Q99973 | |
| LLPRLTPILKNRHEK | 1016 | O75533 | |
| LRLLLPVPHVKLNVQ | 586 | O94759 | |
| TNQVLLHKIPPRKRL | 436 | Q96GC6 | |
| PKLSCPKRLRLHIKQ | 1206 | Q70Z35 | |
| QNRVHPRPLVKLLPK | 81 | P98182 | |
| RQKRSSVLKPLLIQP | 451 | Q9H869 | |
| KILKALNSRRIIPRP | 1091 | Q9H582 | |
| PKSPQQRLLELLHRS | 436 | P10827 | |
| KLPIVRHVKLLNLPA | 536 | Q96Q05 | |
| KILKRHPGLRNILPI | 1036 | Q5TAX3 |